期刊名称:PARASITOLOGY INTERNATIONAL
期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Parasitology International
|
Parasitology International provides a medium for rapid, carefully reviewed publications in the field of human and animal parasitology. Original papers, rapid communications, and original case reports from all geographical areas and covering all parasitological disciplines, including structure, immunology, cell biology, biochemistry, molecular biology, and systematics, may be submitted. Reviews on recent developments are invited regularly, but suggestions in this respect are welcome. Letters to the Editor commenting on any aspect of the Journal are also welcome. |

|
Audience
All parasitologists, including veterinary and medical
Abstracting / Indexing
- EMBASE
- Elsevier BIOBASE
- Helminthological Abstracts
- ISI Science Citation Index
|
- MEDLINE/Index Medicus
- Protozoological Abstracts
- Public Health and Tropical Medicine
- Tropical Diseases Bulletin
|
Instructions to Authors
Submission of a paper to Parasitology International including a revised version, implies the transfer of copyright from the author(s) to the publisher and therefore it is imperative that the corresponding author has obtained the approval of all other authors to the text and that it does not contain information previously published (except as a meeting abstract or by submission of a sequence data to an electronic database) and is not under consideration for publication elsewhere. Publication in Parasitology International is taken to imply the authors willingness to comply with reasonable requests to supply reagents such as recombinant clones and monoclonal antibodies, and sequence data in electronic form to persons lacking access to computer databases.
Submission. Manuscripts in triplicate and including three collated sets of figures (one original set plus duplicate sets of the same quality) ready for the printer should be submitted either to the Editor-in-Chief or one of the regional editors. Manuscripts returned for revision should be returned to the editor within 3 months. Papers accepted for publication should be as concise as possible.
Submission of sequence data to databases. The easiest and preferred method of submitting sequence data is to use the Authorin programme, which is available free of charge for PC or Macintosh systems from GenBank, National Centre for Biotechnology Information, Blgd. 38A, Room 8N-803, 8600 Rockville Pike, Bethesda, MD 20894, USA (voice: +1 301 4962475; fax + 1 3012 4809241; e-mail: authorin@ ncbi.nim.nih.gov). Files generated by Authorin may be sent by e-mail to gb-sub @ncbi.nim.nih.gov or copied to floppy disk and mailed to GenBank. For each sequence, a unique accession number will be issued by the database (within 24 hours if received via e-mail). The accession number should be included as a footnote on the first page of the article: 'Note: Nucleotide sequences data reported in this paper are available in the EMBL, GenBank and DDJB data bases under the accession number(s) -.'If requested, GenBank will withhold release of data until the appearance of your paper. Updates, corrections or notification for publication should be sent to update@ncbi.nim.nih.gov..
Instructions for authors regarding GenBank/DNA sequence linking
DNA sequences and GenBank Accession numbers Many Elsevier journals cite "gene accession numbers" in their running text and footnotes. Gene accession numbers refer to genes or DNA sequences about which further information can be found in the databases at the National Center for Biotechnical Information (NCBI) at the National Library of Medicine. Elsevier authors wishing to enable other scientists to use the accession numbers cited in their papers via links to these sources, should type this information in the following manner:
For each and every accession number cited in an article, authors should type the accession number in bold, underlined text. Letters in the accession number should always be capitalised. (See Example 1 below). This combination of letters and format will enable Elsevier's typesetters to recognize the relevant texts as accession numbers and add the required link to GenBank's sequences.
Example 1: "GenBank accession nos. AI631510, AI631511, AI632198, and BF223228), a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048), and a T-cell lymphoma (GenBank accession no. AA361117)".
Authors are encouraged to check accession numbers used very carefully. An error in a letter or number can result in a dead link.
In the final version of the printed article, the accession number text will not appear bold or underlined (see Example 2 below).
Example 2: "GenBank accession nos. AI631510, AI631511, AI632198, and BF223228), a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048), and a T-cell lymphoma (GenBank accession no. AA361117)".
In the final version of the electronic copy, the accession number text will be linked to the appropriate source in the NCBI databases enabling readers to go directly to that source from the article (see Example 3 below).
Example 3: "GenBank accession nos. AI631510, AI631511, AI632198, and BF223228), a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048), and a T-cell lymphoma (GenBank accession no. AA361117)".
Manuscripts. The preferred medium of final submission to the accepting editor is on disk with accompanying reviewed and revised manuscript (see Electronic manuscripts below). Manuscripts should be in English on numbered pages with double-spaced typing throughout (including tables, legends and reference lists) on one side of the paper only with margins of at least 3 cm all round. They should be divided into: (1) title page-include a succinct title (which should not normally exceed 100 characters and should not contain any subtitles or abbreviations), the names of the authors including a given name for each, the institutions with city, state and country where the work was performed, the name and complete address (including telephone, telefax and e-mail) of the corresponding author, a list of abbreviations and a list of addresses of authors who have moved from the institution where the work was performed, (2)abstract-maximum 250 words, (3)keywords(3-6 indexing terms), (4)introduction, (5)materials and methods, (6)results, (7)discussion, (8)acknowledgements (grant support and technical support to be listed here), (9)references, (10)tables and (11)figure legends. A recent issue of the journal should be consulted for details. In the interests of clarity and brevity, it may sometimes be advantageous to combine the results and discussion into a single section. Everyone makes minor modifications to standard methods. Do not describe standard materials and methods or modifications unless they have significant and demonstrable ability. Do not duplicate descriptions of methodology in the figure legends. Generic and species names should be typed out in full the first time mentioned - in the title, the summary and the text- and thereafter the generic name should be abbreviated. Words or letters to be printed in italics should either be in italics or underlined. The metric system should be used throughout.
Research Notes. These are intended for the publication of brief definitive reports, primarily of complete DNA sequence data, methods, case reports, that do not merit a full length publication. Maximum length is four printed pages, including one or two figures. Only the salient points of a long DNA sequence should be published, as the whole sequence will be available from a computer database. The title, authorship and affiliations will be in the standard format of the journal. The text should not be sectioned, except for references. Essential experimental details may be incorporated into a figure legend. To facilitate rapid publication, authors will be expected to supply high-quality copy and expedite any necessary revisions, although decisions will normally be yes or no, based on the quality and appropriateness of the initial submission.Minireviews Minireviews are initiated on topics of current, significant advancement in the field. The reviews should be short, current, specific and potentially provocative. They should provide a balanced synthesis from the available data rather than a simple regurgitation of results, but not to be overly speculative. If possible, they should provide new concepts and ideas extending across different parasite systems. The text can be divided into simple sections with a succinct abstract. Minireviews will be subjected to the established review process, and published by an accelerated schedule if accepted.
References. In the text, references should be numbered singly in square brackets in order of their citation, e.g., [2,3,5-7]. In the list, references should be numbered in the order of citation in the text, not in alphabetical order. Unpublished data, personal communications and papers in preparation or 'submitted' should not be listed in the references (but may be incorporated at the appropriate place in the text); work 'in press' may be listed only if it has been accepted for publication. Personal communications must be accompanied by a letter from the named person(s) giving permission to quote such information. Abstracts (whether published or not), theses and similar material are not to be quoted in the list. If necessary, they can be referred to in the text in parentheses. Periodicals [1], books [2] and edited books [3] should accord with the following examples;
[1] Perrine KG, Denker JA, Nilsen TW. A multi-copy gene encodes a potentially protective antigen in Brugia malayi. Mol Biochem Parasitol 1988;30: 97-104.
[2] Davis LG, Dibner MD, Battey JF. Basic Methods in Molecular Biology, Elsevier: Amsterdam, 1986.
[3] Chang K-P, Fong D, Bray RS. Biology of Leishmania and leishmaniasis. In: Chang K-P, Bray RS, editors. Leishmaniasis. Amsterdam: Elsevier, 1985: 1-30.
[4] Lai AA, De la Cruz VF, Campbell GH, Procell PM, Collins WE, McCuchan TF. Structure of the circumsporozolte gene of Plasmodium malrize. Mol Biochem Parasitol (in press).
Abbreviations of journal titles should conform to those adopted by the List of the Serial Title Word Abbreviations, ISDS International Centre 20, rue Bachaumont, 75002 Paris, France (ISBN 2-904938-02-8).
Tables. Each table should be typed double-spaced on a separate sheet and have a short descriptive title. A legend may be placed under the table. Footnotes should be identified in the table by a, b, c, etc.
Figures. Figures must be in a form and condition suitable for high quality reproduction. Lettering should be clear and of adequate size to be legible after reduction. Consider the printed page and column proportions when preparing figures. Multiple panels of a single figure must be mounted together. Each DNA sequence figure must fit on a single sheet of paper. Place numbering at one end of each line, not on separate lines, and avoid excessive line spacing. Consider placing nucleotide and protei data in separate panels, using single-letter animo acid abbreviations for the protein sequence and grouping nucleotides either continuously or in blocks of ten separated by one space. Preferably use a sans-serif font. Upper case is standard, except that introns or other features can be usefully distinguished by lower case. Provide sharp laser-printer or imagesetter copy. Nucleotide sequences of long coding regions, where the amino acid sequence is the primary feature, and long DNA sequences may, at the editor's discretion, be omitted from the printed paper. They can be obtained from electronic databases or from the authors. Half-tone illustrations may be included. They should be submitted as black-and-white prints on glossy paper and have as much contrast as possible. A scale should appear on photomicrographs. Colour plates will be published at the expense of the authors. Submission of colour plates implies that authors are prepared to pay these costs. Figure legends should be typed double spaced at the end of the text, not on the figures. Figures should be checked extremely carefully, particularly after revisions. No changes to figures will be possible after acceptance of the manuscript. For assistance on how to prepare your artwork for electronic submission visit: http://www.elsevier.com/locate/authorartwork
Detailed Instructions. Abbreviations, symbols, chemical and biochemical nomenclature, etc, should follow the recommendations given in the Journal of Biological Chemistry (Vol. 268, pp. 14543-14551). Avoid abbreviations which are not in common use across the field of parasitology. Those used should be defined in the text on first usage and listed as a footnote on the title page.Do not introduce abbreviations unless they are used at least 4 times.
Electronic Manuscripts. Electronic manuscripts have the advantage that there is no need for rekeying of text, thereby avoiding the possibility of introducing errors and resulting in reliable and fast delivery of proofs. For the initial submission of manuscripts for consideration, hardcopies are sufficient. For the processing of accepted papers, electronic versions are preferred. After final acceptance, your disk plus one, final and exactly matching printed versions should be submitted together. Double density (DD) or high density (HD) diskettes (3 1/2 or 5 1/4 inch) are acceptable. It is important that the file saved is in the native form of the wordprocessor program used. Label the disk with the name of the computer and wordprocessing package used, your name, and the name of the file on disk. Further information may be obtained from the Publisher.
Proofreading. Proofs should be read carefully and returned by fax or airmail within 2 days of receipt. Corrections should be restricted to typesetting errors; no other alterations will be accepted. Addenda in proofs will be printed only in exceptional cases, and only after approval by the editors.
Reprints. The author will receive an order form with the proofs on which reprints above the 25 free per contribution may be ordered.
Editors.
Editor-in- Chief: Prof. Tsutomu Takeuchi, Dept. of Tropical Medicine and Parasitology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160, Japan. Tel: +81 3 3353 1211; Fax: +81 3 3353 5938, E-mail: takeuchi@sc.itc.keio.ac.jp
Regional Editor (Americas): Prof. Stephen L. Hajduk, Department of Biochemistry and Molecular Genetics, The University of Alabama at Birmingham, 554 Basic Health Sciences Building, 1918 University Boulevard, Birmingham, Alabama 35294-0005, USA; Tel: (205) 934-6033, Fax: (205) 975-2547, E-mail: shajduk@bmg.bhs.uab.edu.
Regional Editor (Europe): Prof. R. Carter, University of Edinburgh, School of Biological Sciences, ICAPB, Ashworth Laboratories, West Mains Road, Edinburgh EH9 3JT, U.K.; Tel: (131) 650 5558, Fax: (131) 668 3861, E-mail: r.carter@ed.ac.uk
Authors in Japan please note: Upon request Elsevier Science Japan will provide authors with a list of people who can check and improve the English of their paper (before submission). Please contact our Tokyo office: Editorial Service, Elsevier Science Japan, Higashi Azabu 1-chome, Building 4F 1-9-15, Higashi Azabu, Minato-ky, Tokyo 106, Japan. Tel: +81 3 5561 5032; Fax +81 3 5561 5045.
Author enquiries. Authors can keep a track on the progress of their accepted article, and set up e-mail alerts informing them of changes to their manuscript's status, by using the "Track a Paper" feature of Elsevier's Author Gateway.
Full details of electronic submission and formats can be obtained from http://authors.elsevier.com.
Editorial Board
Editor-in-Chief:
Tsutomu Takeuchi, Department of Tropical Medicine and Parasitology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. Tel: +81 3 3353 1211, Fax: +81 3 3353 5958, Email: takeuchi@sc.itc.keio.ac.jp
Regional Editor (Americas):
S.L. Hajduk, Director, Ellison Program in Global Infectious Diseases, 7 MBL Street, Marine biological Laboratory, Woods Hole, MA 02543-1015 Tel: (508) 289-7131, Fax: (508) 547-4727, Email: shajduk@mbl.edu
Regional Editor (Europe):
R. Carter, University of Edinburgh, School of Biological Sciences, ICAPB, Ashworth Laboratories, West Mains Road, Edinburgh EH9 3JT, U.K. Tel: +44(0)131 650 5558, Fax: +44(0)131 668 3861, Email: r.carter@ed.ac.uk
Managing Editor:
Takashi Asai, Dept. of Tropical Medicine and Parasitology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. E-mail: asait@med.keio.ac.jp Tel: +81-3-3353-1211, Fax: +81-3-3353-5958
Editorial Board:
Y. Aoki, Nagasaki, Japan N. Arizono, Kyoto, Japan N.R. Bergquist, Geneva, Switzerland A. Bhattacharya, New Delhi, India K.M. Bosompem, Legon, Ghana A. Capron, Lille Cedex, France G.H. Coombs, Glasgow, Scotland G.A.M. Cross, New York, NY, USA W. De Souza, Rio de Janeiro, Brasil Z. Feng, Shanghai, People's Rep. of China W.E. Gutteridge, Geneva, Switzerland D.A. Harn, Boston, MA, USA K. Himeno, Tokushima, Japan K. Hirayama, Institute of Tropical Medicine, Nagasaki University, Japan T. Horii, Departmen of Melecular Protozoology, Osaka University, Osaka, Japan M. Kamiya, Hokkaido, Japan K. Kita, Tokyo, Japan S. Kojima, Tokyo, Japan R. Komuniecki, Toledo, OH, USA S. Lee, Seoul, Korea F.Y. Lieuw, Glasgow, Scotland S. Looareesuwan, Bangkok, Thailand J.W. Mak, Kuala Lumpur, Malaysia D.P. McManus, Brisbane, OLD, Australia H. Mehlhorn, Düsseldorf, Germany R.S. Nussenzweig, New York, NY, USA K. Ogawa, Graduate School of Agriculture, University of Tokyo, Tokyo, Japan S.C. Parija, Pondicherry, India W.A. Petri, Virginia, USA M. Rommel, Hannover, Germany A. Sher, Bethesda, MD, USA M. Suzuki, Gunma, Japan K. Tanabe, Osaka, Japan M. Tanner, Basel, Switzerland E. Tannich, Hamburg, Germany W.U. Tiu, Manila, Philippines M. Torii, Department of Parasitology, Ehime University, Ehime, Japan C.C. Wang, San Francisco, CA, USA
|